A drug with the SMILES CC(C)N1CCC(n2nccc2NC(=O)c2ccc3c(c2)OCO3)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 12.034\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(C)N1CCC(n2nccc2NC(=O)c2ccc3c(c2)OCO3)CC1
CC(C)N1CCC(n2nccc2NC(=O)c2ccc3c(c2)OCO3)CC1
N-[2-(1-propan-2-ylpiperidin-4-yl)pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide